TRANSCEND Program Phase 3 Type 2 Diabetes Trials Study Design : Global Phase 3 randomized clinical trial program evaluating retatrutide in adults with type 2 diabetes
As an incretin hormone, GLP-1 increases insulin release when blood sugar rises after meals and reduces glucagon levels, helping maintain stable glucose levels
Epidemiological data further demonstrate that over 90% of individuals with BD experience recurrent episodes, which contribute to progressive neurobiological changes, cognitive decline, and increased medical and psychiatric comorbidities (Nierenberg et al., 2023)
Additionally, the brand provides specialized products like melatonin, lutein, and collagen, designed to support cellular function and overall well-being
But without treatment, some can lead to bradyarrhythmia (irregularly slow heartbeat) and even cardiac arrest (when your heart stops beating)
US Patent, Publication Number US10526616B2 Wang ZY, Zhao Y, Ren L et al (2008) Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy
